Convolutional neural network based Alzheimer’s disease classification from magnetic resonance brain images

2019 ◽  
Vol 57 ◽  
pp. 147-159 ◽  
Author(s):  
Rachna Jain ◽  
Nikita Jain ◽  
Akshay Aggarwal ◽  
D. Jude Hemanth
2021 ◽  
Vol 2021 ◽  
pp. 1-9
Author(s):  
Fanar E. K. Al-Khuzaie ◽  
Oguz Bayat ◽  
Adil D. Duru

There are many kinds of brain abnormalities that cause changes in different parts of the brain. Alzheimer’s disease is a chronic condition that degenerates the cells of the brain leading to memory asthenia. Cognitive mental troubles such as forgetfulness and confusion are one of the most important features of Alzheimer’s patients. In the literature, several image processing techniques, as well as machine learning strategies, were introduced for the diagnosis of the disease. This study is aimed at recognizing the presence of Alzheimer’s disease based on the magnetic resonance imaging of the brain. We adopted a deep learning methodology for the discrimination between Alzheimer’s patients and healthy patients from 2D anatomical slices collected using magnetic resonance imaging. Most of the previous researches were based on the implementation of a 3D convolutional neural network, whereas we incorporated the usage of 2D slices as input to the convolutional neural network. The data set of this research was obtained from the OASIS website. We trained the convolutional neural network structure using the 2D slices to exhibit the deep network weightings that we named as the Alzheimer Network (AlzNet). The accuracy of our enhanced network was 99.30%. This work investigated the effects of many parameters on AlzNet, such as the number of layers, number of filters, and dropout rate. The results were interesting after using many performance metrics for evaluating the proposed AlzNet.


2020 ◽  
Vol 10 (1) ◽  
Author(s):  
Jong Bin Bae ◽  
Subin Lee ◽  
Wonmo Jung ◽  
Sejin Park ◽  
Weonjin Kim ◽  
...  

AbstractThe classification of Alzheimer’s disease (AD) using deep learning methods has shown promising results, but successful application in clinical settings requires a combination of high accuracy, short processing time, and generalizability to various populations. In this study, we developed a convolutional neural network (CNN)-based AD classification algorithm using magnetic resonance imaging (MRI) scans from AD patients and age/gender-matched cognitively normal controls from two populations that differ in ethnicity and education level. These populations come from the Seoul National University Bundang Hospital (SNUBH) and Alzheimer’s Disease Neuroimaging Initiative (ADNI). For each population, we trained CNNs on five subsets using coronal slices of T1-weighted images that cover the medial temporal lobe. We evaluated the models on validation subsets from both the same population (within-dataset validation) and other population (between-dataset validation). Our models achieved average areas under the curves of 0.91–0.94 for within-dataset validation and 0.88–0.89 for between-dataset validation. The mean processing time per person was 23–24 s. The within-dataset and between-dataset performances were comparable between the ADNI-derived and SNUBH-derived models. These results demonstrate the generalizability of our models to different patients with different ethnicities and education levels, as well as their potential for deployment as fast and accurate diagnostic support tools for AD.


Sign in / Sign up

Export Citation Format

Share Document